Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North
P.O. Box 19024
Seattle
Washington
98109-1024
United States
Tel: (206) 667-4700
Website: http://www.fredhutch.org/
186 articles with Fred Hutchinson Cancer Research Center
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Cellares Welcomes Fred Hutchinson Cancer Research Center Into Its Early Access Partnership Program
10/29/2020
Under the Collaboration, Fred Hutch Will Provide Input and Share Expertise Supporting Development of Cellares' Innovative Manufacturing Platform
-
Matrix Medical Network to Support COVID-19 Vaccine Trials as Part of Operation Warp Speed
10/1/2020
Matrix Medical Network ® (Matrix) will be a key enabler in clinical trials of investigational COVID-19 vaccines conducted by the COVID-19 Prevention Network. Matrix Clinical Solutions, through an agre
-
SpringWorks Therapeutics Enters into Sponsored Research Agreement with Fred Hutchinson Cancer Research Center to Further Evaluate Nirogacestat as a BCMA Potentiator in Multiple Myeloma
9/18/2020
SpringWorks Therapeutics, Inc. announced that it has entered into a sponsored research agreement with Fred Hutchinson Cancer Research Center to further explore the ability of SpringWorks’ investigational gamma secretase inhibitor, nirogacestat, to modulate B-cell maturation antigen and potentiate BCMA-targeting therapies, including radioimmunotherapies, in a variety of preclinical and patient-derived multiple myeloma models developed by researchers at Fred Hutch.
-
Could gene therapy provide a solution to HIV? A new research project aims to find out.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Lonza Collaborates with Immunotherapy Leaders to Assess Point-of-Care Manufacturing for Cancer Cell Therapies
3/9/2020
“We are extremely motivated to be working hand-in-hand with these premier institutes, among the leaders in cell-based immunotherapy discovery and development, to exhibit the use of the closed, automated Cocoon® Platform for manufacturing cell therapies.
-
The mandatory work-from-home policy will remain in effect through March 31, but could be extended depending on circumstances.
-
Alkermes Announces Clinical Collaboration With Fred Hutchinson Cancer Research Center for Novel Immuno-Oncology Drug Candidate ALKS 4230
10/21/2019
Planned Phase 2 Multi-Site Trial to Evaluate ALKS 4230 in Combination With Pembrolizumab in Patients With Advanced or Recurrent Head and Neck Squamous Cell Cancer
-
ElevateBio Launches HighPassBio to Advance Novel Targeted T Cell Immunotherapies with Technology from Fred Hutchinson Cancer Research Center
10/1/2019
T cell receptor (TCR) T cell therapy targeting HA-1 expressing tumors designed to manage post-hematopoietic stem cell transplant leukemic relapse
-
Hyundai Hope On Wheels Presents Fred Hutchinson Cancer Research Center With $300,000 Hyundai Scholar Hope Grant To Support Pediatric Cancer Research
9/24/2019
The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research. [24-September-2019] SEATTLE , Sept. 24, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyun
-
Fred Hutchinson Cancer Research Center and Leica Microsystems Establish Center of Excellence in Microscopy
9/3/2019
Fred Hutchinson Cancer Research Center and Leica Microsystems, Inc. have combined efforts to establish the Leica Microsystems Center of Excellence at Fred Hutch.
-
EpiCypher® announces the launch of CUTANA™ (ChIC / CUT&RUN / CUT&Tag) for next-generation genomic mapping studies
7/23/2019
EpiCypher, Inc. announces the commercial licensing of ChIC (University of Geneva) and CUT&RUN / CUT&Tag (Fred Hutchinson Cancer Research Center) technologies.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
A recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle—which happens to be the BioSpace Bio Forest Hotbed—as the fastest-growing life science market in the top 10 from 2014 to 2017, with a greater than 17-percent growth.
-
January 25 Research Roundup: Alzheimer’s Memory Recovery and Testing, New Antibiotics, Possible S...
1/25/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Gene Therapy, Gene Editing and Immuno-Oncology Creating Thousands of New Job Opportunities
10/22/2018
The U.S. Bureau of Labor Statistics predicts a 7 percent increase in jobs for biomedical engineers and a 13 percent increase in medical scientists. -
GO Therapeutics, headquartered in Cambridge, Mass., signed a licensing deal with Swiss-based Roche to develop antibodies for cancer.
-
Some cancer cells have a remarkable and frightening sense of self-preservation to avoid immunotherapy treatments. That is the finding from a new study conducted by researchers at the Fred Hutchinson Cancer Research Center in Seattle.
-
By many standards, and certainly by the way the media covers it and industry promotes it, immuno-oncology therapies using CAR-T are revolutionizing cancer treatments. But what if, as the saying goes, they threw a revolution and nobody came? Or more precisely, what if they threw a revolution and n...